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ABSTRACT
Background: Antimicrobial resistance is described as a condition in which a micro-organism is able to survive when exposed 
to an antimicrobial agent. The resistance rates to antimicrobials in companion animals have risen considerably. Studies of local 
antimicrobial susceptibility profiles are needed as well as education and warning about the use of tests for the identification and 
susceptibility of pathogenic bacterial strains. The aim of this study was to identify the main antimicrobial resistance in clinical 
samples of dogs, and to detect multidrug-resistant strains of importance to public health.
Materials, Methods & Results: Bacterial pathogens of 77 dog infections were isolated and their sensitivity profile to antimicrobi-
als was determined. One hundred bacterial isolates were identified. Of these, 61 were Gram-positive (55 Staphylococcus spp., 4 
Enterococcus spp. and 2 Streptococcus spp.) and 39 Gram-negative (36 fermenters and 3 non-fermenters). Seventy-nine isolates 
were considered multiresistant following individual assessment of drugs, and 85 following the evaluation of classes. Only 3 
were sensitive to all drugs. Four isolates were resistant to all classes and only sensitive to some antibiotics. Of the 55 samples of 
Staphylococcus spp., 36 (65.45%) were identified as phenotypically MRS. Two isolates of Enterococcus spp. were resistant to 
vancomycin (VRE). Also 66.67% (26/39) of the samples were positive for the presumptive test for ESBL. For the MRS-positive 
isolates detected in this study, chloramphenicol was the antimicrobial that showed superior sensitivity in 74.29% of the cases 
(27/36); therefore it is considered the most appropriate for treatment of this type of micro-organism. In case of aminoglycosides, 
when their resistance was checked in MRS isolates, all resistance percentages increased, implying a limited use of this class for 
such a type of multi-resistant micro-organism. Contrarily, in case of ESBL, a superior sensitivity was observed towards MRS 
isolates, thus making them a prime treatment choice for the infection caused by these micro-organisms.
Discussion: Literature have reported a gradual increase in multidrug resistance towards antimicrobial agents in veterinary medicine 
over the past decades. In this study, 64% of multiresistant strains were considered of significant importance, notably MRS (36), 
VRE (2) and ESBL (26). The early identification of pathogens in animals has become an important step in order to minimize 
the transmission of antibacterial resistance. The increase in the number of multidrug-resistant bacteria in animals and humans 
demonstrates the need to develop and implement measures in order to monitor and control the spread of this resistance. It is pos-
sible that the increased drug resistance is linked to the constant exposure to these drugs and the subsequent selective pressure, 
causing the transfer of resistant genes between strains. Carbapenems and glycopeptides should be used with caution in veterinary 
medicine in order to prevent such processes of selection that develop resistance in micro-organisms to these two classes, which 
can result in cross-resistance between animals and humans and create obstacles in the treatment of patients, especially for the 
two drugs mentioned, since they are important for the treatment of nosocomial infections in humans. The resistance percentage 
towards fluoroquinolones was identified to be higher in Gram-positive isolates, particularly in MRS, which showed 75% resis-
tance against this class (according to the CLSI, resistance to one fluoroquinolone antimicrobial agent provides resistance to other 
antimicrobials of this class). For ESBL isolates, the resistance was shown to be 50%. The resistance towards the fluoroquinolones 
and aminoglycosides class can be associated with the expression of the genes that produce ESBL.
Keywords: ESBL, MRS, multidrug resistance, public health, VRE.
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INTRODUCION
Antimicrobial resistance is described as a con-
dition which a micro-organism is able to survive upon 
exposure to an antimicrobial agent [5]. According to 
Ishii et al. [18], the emergence of multidrug-resistant 
strains creates failures in the treatment of various 
infections, and this due to the inappropriate use of 
antimicrobial drugs, which contributes to the develop-
ment of bacterial resistance in animals and humans.
Due to the close contact of e.g. dogs and cats 
to man, and the indiscriminate use of antibiotics in 
veterinary medicine, these animals become a potential 
source of resistant bacteria for humans, and vice-versa, 
potentially leading to the transmission of multiresistant 
bacteria interspecies [17].
Several steps must be taken to combat multi-
drug-resistant micro-organisms in order to prevent the 
severe impact on public health, especially the conscious 
use of antimicrobials, a correct administration route 
and a monitoring of the resistance profile by antibio-
gram techniques [15].
The resistance rates towards antimicrobials in 
companion animals have risen considerably. Studies of 
local antimicrobial susceptibility profiles are needed 
as well as proper education and warning about the 
use of tests for the identification and susceptibility 
of pathogenic bacterial strains [18,27]. Thus, the aim 
of this study was to identify the main antimicrobial 
resistance in clinical samples of dogs and to detect 
the multidrug-resistant bacterial pathogens involved.
MATERIALS AND METHODS
Samples of 77 dogs, treated at the Veterinary 
Hospital of the State University of Maringá (UEM), 
Regional Campus Umuarama (CAU), were used in this 
study. The samples were sent to the Animal Microbiol-
ogy Laboratory - UEM / CAU.
The samples were initially incubated in Brain 
Heart Infusion broth - BHI (Brain Heart Infusion)¹ at 
36°C for 2 to 18 h, then plated on Blood agar (5% sheep 
blood defibrillated in Nutrient Agar¹ and MacConkey 
Agar¹. The isolates were identified based on colony 
morphology and biochemical reaction [1]. 
Antimicrobial susceptibility tests were per-
formed through the disk diffusion method on Muller 
Hinton agar¹ according to Bauer et al. [6]. The zone 
sizes were interpreted by CLSI [7,8]. The antimicrobial 
agents tested were β-lactam penicillins: penicillin G 
(10U); β-lactam aminopenicillin: amoxicillin (10 μg) 
and ampicillin (10 μg); β-lactam/β-lactamase inhibitors 
combinations: amoxacillin-clavulanic acid (30 mcg) and 
ampicillin-sulbactan (20 μg); β-lactam penicillinase-
stable penicillins: oxacillin (1 μg); β-lactam cepha-
losporin: first generation - cephalexin (30 mcg) and 
cephalothin (30 μg), 3rd generation - ceftriaxone (30 
μg), ceftazidime (30 μg) and cefotaxime (30 μg) and 
4th generation - cefepima (30 μg); β-lactam cephems: 
cefoxitin (30 mcg); β-lactam monobactams: aztreonam 
(30 μg); β-lactam carbapenems: imipenem (10 mcg) 
e meropenem (10 μg); Glycopeptides: vancomycin 
(30 μg); Polypeptides: polymyxin (300 μg); Amino-
glycosides: gentamicin (10 μg), streptomycin (10 μg), 
amikacin (30 μg), neomycin (30 μg) and tobramycin (10 
μg); Macrolides: 14-membered rings - erythromycin (15 
μg) and 15-membered rings - azithromycin (15 μg); Lin-
cosamides: clindamycin (2 μg); Ansamycin: rifampin (5 
μg); Phenicols: chloranphenicol (30 μg); Nitrofurantoin: 
nitrofurantoin (10 mcg); Fluoroquinolone: enrofloxacin 
(05 μg), norfloxacin (10) μg, ciprofloxacin (5 μg) and 
levofloxacin (5 μg); Tetracyclines: tetracycline (30 μg) 
and doxycycline (30 μg); Folate pathway inhibitors: 
trimethoprim-sulfamethoxazole (25 μg) [Newprov®]².
Phenotypic detection of multidrug-resistant 
strains that are of public health significance was per-
formed by disk diffusion with: oxacillin and cefoxitin 
to Methicillin-Resistant Staphylococcus (MRS) [7,8]; 
synergism between amoxicillin-clavulonic acid and 
aztreonam, ceftazidime, cefotaxime, ceftriaxone, ce-
fepime to Extended-spectrum beta-lactamase (ESBL) 
producing Gram-negative [8,30]; and vancomycin to 
Vancomycin-Resistant Enterococcus (VRE) [7].
 The Multiple Antibiotic Resistance index 
(MAR) was calculated as the number of resistant rat-
ings across the total number tested [19]. The Multiple 
Antimicrobial Classes Resistance index (MCR) was 
calculated as the ratio between the number of classes 
considered resistant (at least one drug per class) and 
the total number of classes tested. A ratio larger than 
or equal to 0.25 was considered multirresistant [23]. 
The results were submitted for descriptive 
analysis in order to calculate absolute and relative 
frequencies [27].
RESULTS 
The 77 analyzed samples originated from dif-
ferent locations/distribution systems. The bacterial 
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frequency in the different samples is shown in Table 1. 
The overall resistance rate was 45.24% for skin infec-
tions, 35.13% for conjunctivitis, 33,12% for cystitis, 
29.92% for piometras, 28.82% for otitis, 22.62% for 
superior respiratory tract infections and 37.22% for 
other types of infections.
Pure colonies were isolated from 59 samples, 
whereas mixed cultures with two bacterial types were 
isolated in 14 samples, with three bacterial types in 3 
samples and with four bacterial types in just one sample. 
100 bacterial isolates were identified, as shown in Table 
2. The antimicrobial resistance rates (MAR), for which 
indices ≥ 0.2 indicate multidrug resistance, varied be-
tween 0 and 0.93. In this study, 79 out of 100 isolates 
(79%) showed multidrug resistance, and nine isolates 
showed a MAR index higher than 0.8 (8 Staphylococ-
cus CP and Enterobacter sp.). Only three isolates were 
sensitive to all drugs tested. Considering the MCAR 
index, 85% of the samples had an index greater than 
0.25, and showed resistance to three or more classes of 
antimicrobials. The average MCAR index of the samples 
studied was 0.49. Four samples were resistant to at least 
one antimicrobial of all classes tested (two Staphylococ-
cus CP, one E. coli and one Enterobacter sp.).
A total of 2723 tests with antimicrobial drugs 
were performed in this study: 35.92% (978) were 
considered resistant, and 9.51% (259) were considered 
to have intermediate resistance, and finally 45.43% 
(1237) of the samples showed only slight resistance 
level. Samples reported with intermediate resistance 
were counted as resistant for statistical purposes, since 
it is not advisable to use these antimicrobials in clinical 
medicine. The resistance rates of 100 isolates for each 
antimicrobial are shown in Figure 1.
Oxacillin and cefoxitin are, according to CLSI 
[7], predictive drugs for resistance in Staphylococcus 
spp. to all beta-lactam antibiotics, which is called MRS. 
In this study, of the 55 samples of Staphylococcus 
spp., 36 (65.45%) were resistant to oxacillin and/or 
cefoxitin, which demonstrates the presence of MRS.
The results of this study, through use of the 
disk diffusion technique, show that of the 55 samples 
of Staphylococcus spp., 32 (58.18%) were susceptible 
in vitro to vancomycin and 23 need further assessment 
for minimal inhibitory concentration (MIC) for this 
antimicrobial. According to CLSI [7], vancomycin 
resistant Staphylococcus (VRS) can only be reported, 
through MIC. For Enterococcus spp., through disk dif-
fusion technique, which were found two VRE strains, 
both with MAR rates higher than 0.2.
In this study, 66.67% (26/39) of Gram-negative 
isolates tested positive in the presumptive test for detec-
tion of ESBL. Of these, seven (26.92%) E. coli were 
isolated, as were four (15.38% ) Providencia spp. and 
Proteus spp., three (11.54%) Enterobacter spp., and 
two (7.69%) Pantoea agglomerans, Citrobacter spp., 
Pseudomonas spp. and Serratia spp. Of the 26 ESBL 
samples, only three (11.54%) showed a MAR index 
below 0.2. This confirms the presence of multidrug 
resistance in these micro-organisms.
The resistance profiles of the main multire-
sistant micro-organisms (MRS, VRE and ESBL) are 
shown in Figures 2 and 3; the indices MAR and MCAR 
are shown in Table 3.
Table 1. Distribution in overall frequency and MAR frequency ≥0.2 of the bacterial strains found in different organ systems of infected dogs from Vet-
erinary Hospital of the State University of Maringa, PR, Brazil.
Bacterial isolates Gram positive Gram negative Total
Sample Total MAR ≥0.2
Fermenters No Fermenters Total MAR ≥0.2
Total MAR ≥0.2 Total MAR ≥0.2
Skin 17 16 12 10 0 0 29 26
Ophthalmic 15 10 6 4 0 0 21 16
Ear infections 13 7 1 1 2 2 16 13
Vaginal 8 6 9 6 0 0 17 13
Urinary 1 0 4 3 1 1 6 4
nasal discharge 4 1 2 1 0 0 6 2
Mammary 1 1 0 0 0 0 1 1
Bone 0 0 1 1 0 0 1 1
Oral 1 1 0 0 0 0 1 1
Others 1 1 1 1 0 0 2 2
Total 61 43 36 27 3 3 100 79
MAR = Multiple Antibiotic Resistance index.
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Table 2. Distribution frequency, MAR indices and MCAR medium and frequency of multidrug-resistant bacteria found in bacterial isolates from dog 
infections from Veterinary Hospital of the State University of Maringa, PR, Brazil.
Bacterial isolates Frequency Average MAR Freq MAR ≥0.2 Average MCR
Freq
MCR ≥0.25
Cocci G+
Staphylococcus spp. 55 0.447 41 0.566 45
Enterococcus spp. 4 0.333 2 0.432 3
Streptococcus spp. 2 0.206 1 0.285 1
Total G+ 61 0.329 44 0.428 49
Gram -
Fermenters
Escherichia coli 12 0.433 10 0.552 10
Enterobacter spp. 4 0.506 4 0.597 4
Proteus spp. 4 0.416 4 0.520 4
Providencia spp. 4 0.282 3 0.440 4
Serratia spp. 3 0.487 3 0.630 3
Pantoea agllomerans 3 0.448 2 0.533 2
Citrobacter spp. 2 0.517 2 0.625 2
Salmonella spp. 1 0.226 1 0.380 1
Unidentified 3 0.452 3 0.537 3
No Fermenters
Pseudomonas spp. 3 0.639 3 0.797 3
Total G- 39 0.441 35 0.561 36
Grand Total 100 0.385 79 0.494 85
*MAR = Multiple Antibiotic Resistance index; MCR = Multiple Antimicrobial Classes Resistance index.
Table 3. Distribution frequency, MAR indices and MCAR from MRS isolated, VRE and ESBL isolated from dog infections in Veterinary Hospital of 
the State University of Maringa, PR, Brazil.
Total Total (%) Frequency MAR >2 Average MAR Frequency MCR Average MCR
MRS 36 (55) 65.45 35 0.575 35 0.63
ESBL 26 (39) 66.67 23 0.448 25 0.46
VRE 2 (4) 50 2 0.532 2 0.6
*MAR = Multiple Antibiotic Resistance index; MCR = Multiple Antimicrobial Classes Resistance index; MRS = Methicillin-Resistant Staphylococcus; 
ESBL = Extended-spectrum beta-lactamase; VRE = Vancomycin-Resistant Enterococcus.
Figure 1. Antimicrobial resistance profile in samples isolated from dogs in HV-UEM, PR, Brazil.
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Figure 2. Percentage of antimicrobial resistance of MRS and VRE isolated in samples from dogs treated at the HV-UEM, PR, Brazil.
Figure 3. Percentage of antimicrobial resistance of ESBL isolated in samples of dogs treated in HV-UEM, PR, Brazil.
DISCUSSION 
With regard to the multidrug resistance index, 
Arias et al. [3] studied samples of infected surgical 
wounds, and found 19 out of 23 samples (82.6%) to 
have a MAR index ≥ 0.2, three of which with a value 
of 1. Sfaciotte et al. [27] isolated 89.4% of the ana-
lyzed samples with a MAR index ≥ 0.2. Both studies 
thus registered a high index medium, however only a 
few samples were studied and only a few antimicro-
bial drugs were tested. Some authors have reported a 
gradual increase in multidrug resistance to antimicrobi-
als in veterinary medicine over the past decades [2,22].
In this study, in 64% (64/100) of tested 
samples, multiresistant strains of high importance 
were detected, such as MRS (36), VRE (2) and 
ESBL (26). The early identification in animals has 
become an important step in minimizing the trans-
mission of antibacterial resistance. The increase in 
the number of multidrug-resistant bacteria in animals 
and humans demonstrates the need to develop and 
implement measures that monitor and control the 
diffusion of this resistance [18,28]. It is possible 
that the increased resistance is linked to the constant 
exposure to these drugs and the subsequent selective 
pressure caused by the transfer of resistance genes 
between strains [29].
Methicillin resistance is the most important 
mechanism of antimicrobial resistance in Staphylococ-
cus sp. identified so far. Resistant isolates of S. pseud-
intermedius methicillin (MRSP) have been reported 
worldwide in veterinary clinics and hospitals. MRSP 
bacteria are recognized as a major pathogen due to 
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multidrug resistance and the associated difficulty in 
treatment of infections [17,28]. 
One of the most important mechanisms of 
resistance found in the Enterobacteriaceae family of 
micro-organisms is the desactivation through hydroly-
sis of the beta-lactam ring by enzymes. These bacteria 
are beta-lactamasis producers of extended spectrum 
(ESBL), which gives resistance to antimicrobial agents 
of the cephalosporins and monabactams classes [25], 
although they do not hydrolyze cephamycins and car-
bapenems. These antimicrobials are also desactivated 
by beta-lactamase inhibitors (clavulanic acid, sulbac-
tam and tazobactam) [20]. A major study on ESBL 
detection on small animals was conducted in Germany 
and resistance genes were detected for E. coli, Sal-
monella enterica, Proteus mirabilis and Enterobacter 
cloaceae through isolation from wounds, as well as 
urinary and respiratory infections [13]. 
Of 19 methicillin-sensitive strains of Staphylo-
coccus sp. (MSS), 84.21% were sensitive to cephalex-
in, 78.95% to cephalothin and 89.47% to ceftriaxone. 
Therefore, their use is advisable. These antimicrobials 
are recommended to be used in a medical and surgical 
veterinary clinic environment. There is however no 
such recommendation for MRS samples.
The carbapenems are beta-lactam antimicro-
bial agents, and they are usually the last choice for 
treatments. They are used for ESBL producing micro-
organisms and nowadays are often used for the treatment 
of human nosocomial infections. However, the presence 
of resistant isolates for carbapenems is already being 
reported through the expression of carbapenemases [31].
In this study, 30.3% and 43.75% of ESBL 
samples showed some level of resistance to meropenem 
and imipenem respectively. It indicates that there is a 
requirement for the development of more specific tests 
to detect the presence of resistance genes that encode 
carbapenemases. Although there are no clear rules that 
prohibit the use of carbapenems in veterinary medicine, 
these antibiotics should be used with caution in order 
to avoid the pressure of selection of resistant clones 
and the transmission of resistance to other bacteria, 
potentially affecting humans [28].
Vancomycin is a major antimicrobial used for 
the treatment of infections caused by Enterococcus 
spp. and MRS in human medicine. However, with the 
emergence of VRE and VRSA, there are only a few 
therapeutic agents capable of treating infections caused 
by these micro-organisms [16]. This agrees with the 
results found in this study, where the two identified 
VRE strains were resistant to most of the antimicrobial 
classes tested. In veterinary medicine, no samples of 
VSRA were identified [22].
Under these circumstances, the presence of 
VRE, VRSA and MRS should be extensively moni-
tored in veterinary hospital environments, reporting 
the ocurrence of any cases and investigating its origin. 
Carbapenems and glycopeptides also should be used 
with caution in veterinary medicine in order to prevent 
the selection of resistant micro-organisms towards 
these two classes. Otherwise, cross-resistance between 
animals and humans can occur, which can vastly com-
plicate the treatment of patients in these two areas.
With regard to the aminoglycoside class of an-
tibiotics, five drugs were tested and all of them showed 
a better efficacy in Gram-negative isolates, except for 
neomycin. When the resistance in MRS isolates was 
checked, all percentages showed an increase. It limits 
the use of this class for such types of multi-resistant 
micro-organisms. The opposite proved to be the case 
for ESBL, showing better sensitivity for these drugs, 
and as a result making them eligible for treatment of 
infections caused by these micro-organisms. 
Macrolides, lincosamides and streptogramin B 
form the MLSB group of antibiotics because, despite 
different formulas, they have the same action mecha-
nism and epidemiologically the cross-resistances be-
tween these three classes are very important [14] due 
to their wide use in veterinary medicine. In this study, 
94.4% (34/36) of the MRS strains were resistant to at 
least one antibiotic of the MLSB group.
Fluoroquinolones, especially enrofloxacin, are 
one of the main antibiotics used in veterinary medicine, 
because as well as their easy acquisition they prove 
efficient for most empirical antimicrobial treatments, 
and present relative safety, a broad action spectrum 
and strong diffusion in key organs and tissues [24].
The percentage resistant to fluoroquinolones 
was higher in Gram-positive isolates, particularly in 
MRS, which showed 75% of resistance against the 
class (according to the CLSI, resistance to antimi-
crobial agent of fluoroquinolones confers resistance 
to the entire class). For ESBL isolates, the resistance 
was 50%. The resistance class of fluoroquinolones and 
aminoglycosides may be associated with the expression 
of gene producers of ESBL [10].
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For isolated MRS detected in this study, 
chloramphenicol was the antimicrobial that showed 
the highest sensitivity, 74.29% (27/36); thus it is the 
most suitable antimicrobial for treatment of this type 
of micro-organism. In the PABA class of inhibitors, 
Sfaciotte et al. [27] found resistance in 100% of the 
samples studied, Arias et al. [3] concluded 92.3% 
(12/13) in samples of contaminated and infected 
wounds, and according to Dal-Bo et al. [12] 75% to 
Staphylococcus sp. and 50% to Gram-negative bacilli. 
These high rates of antimicrobial resistance of the sulfa 
class can be explained due to its wide use since many 
years in veterinary medicine, often without adequate 
criteria [11].
CONCLUSION
The results of this study indicate that the main 
isolated micro-organism infection in different canine 
organ systems is Staphylococcus spp., followed by 
Gram-negative bacilli fermenting sugars, which belong 
to Enterobactereacea family.
Multiresistant strains of high importance to 
public health were detected, such as MRS, VRE, ESBL. 
It demonstrates the need for constant monitoring of 
bacterial resistance profiles, which vary over the years 
and differ from site to site. The use of tests for bacterial 
identification and their susceptibility to antimicrobials 
can help in the appropriate selection of an antimicrobial 
agent. It is essential for medical and surgical environ-
ments due to the high bacterial resistance rates seen 
in this and other studies, as well as the monitoring 
of local resistances with the continued use of certain 
antimicrobial drugs.
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